Show notes
In this episode, we take a practical approach to the management of anaemia in chronic kidney disease. We discuss the principles of treatment, and key considerations in patient care. We also explore erythropoiesis-stimulating agents (ESAs) and hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), including their mechanisms of action, indications, contraindications, and how to apply current guidance in everyday clinical practice.
Website: podomatic.com

